ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Now, those patients with low HER2 status might be eligible for targeted treatment and a significant potential improvement in outcome, as they will be considered for the specifically engineered ...

Patients and Methods: A total of 320 patients with AOC were centrally screened for HER2 status (243 patients in fi rst line, 77 in relapse). All positive (IHC 3+) and doubtful (IHC 2+) cases were ...

Timely receipt of guideline-concordant care can improve survival and may help mitigate racial and ethnic disparities in survival among patients with inflammatory breast cancer, researchers wrote.

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

Seagen is a specialist in antibody-drug conjugates, but has looked to Chinese biotech RemeGen for a HER2-targeting candidate that could challenge rival drugs from AstraZeneca/Daiichi Sankyo and Roche.

Click on the status to view our full coverage ... Tyrosine kinase inhibitor that selectively blocks HER2 Treatment of adult patients with unresectable or metastatic non-small cell lung cancer ...

Prediction of HER2 overexpression status and IHC score as seen in "Predicting the HER2 status in esophageal cancer from tissue microarrays using convolutional neural networks".

IGNOU Assignment Submission Status Link: The Indira Gandhi National Open University (IGNOU) provides students with the convenience of checking their assignment, practical, and project submission ...

Samuel Colin Day died from an apparent self-inflicted gunshot wound, police said Munford High School A Tennessee community is mourning a teacher who was found dead in a classroom earlier this week ...